1 Min Read
Jan 5 (Reuters) - Arno Therapeutics Inc
* Arno therapeutics announces update to onapristone prostate cancer development program Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.